Blood Cancer Journal (Sep 2024)

Large B-cell lymphomas with CCND1 rearrangement have different immunoglobulin gene breakpoints and genomic profile than mantle cell lymphoma

  • Ece Özoğul,
  • Anna Montaner,
  • Melina Pol,
  • Gerard Frigola,
  • Olga Balagué,
  • Charlotte Syrykh,
  • Pablo Bousquets-Muñoz,
  • Romina Royo,
  • Juliette Fontaine,
  • Alexandra Traverse-Glehen,
  • Marco M. Bühler,
  • Luca Giudici,
  • Marco Roncador,
  • Thorsten Zenz,
  • Sylvain Carras,
  • Severine Valmary-Degano,
  • Laurence de Leval,
  • Jan Bosch-Schips,
  • Fina Climent,
  • Julia Salmeron-Villalobos,
  • Melika Bashiri,
  • Silvia Ruiz-Gaspà,
  • Dolors Costa,
  • Sílvia Beà,
  • Itziar Salaverria,
  • Eva Giné,
  • Leticia Quintanilla-Martinez,
  • Pierre Brousset,
  • Mark Raffeld,
  • Elaine S. Jaffe,
  • Xose S. Puente,
  • Cristina López,
  • Ferran Nadeu,
  • Elias Campo

DOI
https://doi.org/10.1038/s41408-024-01146-z
Journal volume & issue
Vol. 14, no. 1
pp. 1 – 10

Abstract

Read online

Abstract Mantle cell lymphoma (MCL) is genetically characterized by the IG::CCND1 translocation mediated by an aberrant V(D)J rearrangement. CCND1 translocations and overexpression have been identified in occasional aggressive B-cell lymphomas with unusual features for MCL. The mechanism generating CCND1 rearrangements in these tumors and their genomic profile are not known. We have reconstructed the IG::CCND1 translocations and the genomic profile of 13 SOX11-negative aggressive B-cell lymphomas using whole genome/exome and target sequencing. The mechanism behind the translocation was an aberrant V(D)J rearrangement in three tumors and by an anomalous IGH class-switch recombination (CSR) or somatic hypermutation (SHM) mechanism in ten. The tumors with a V(D)J-mediated translocation were two blastoid MCL and one high-grade B-cell lymphoma. None of them had a mutational profile suggestive of DLBCL. The ten tumors with CSR/SHM-mediated IGH::CCND1 were mainly large B-cell lymphomas, with mutated genes commonly seen in DLBCL and BCL6 rearrangements in 6. Two cases, which transformed from marginal zone lymphomas, carried mutations in KLF2, TNFAIP3 and KMT2D. These findings expand the spectrum of tumors carrying CCND1 rearrangement that may occur as a secondary event in DLBCL mediated by aberrant CSR/SHM and associated with a mutational profile different from that of MCL.